SCHEMBL22563489

SCHEMBL22563489

N#Cc1c(-n2c3ccccc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc1-n1c2ccccc2c2cc(-c3ccc(C(F)(F)F)cc3C(F)(F)F)ccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.38
ALDH1A1 P00352 4/20 0.38
L3MBTL1 Q9Y468 4/20 0.38
HPGD P15428 4/20 0.38
TDP1 Q9NUW8 3/20 0.38
GAA P10253 1/20 0.38
NPSR1 Q6W5P4 2/20 0.36
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
SQOR Q9Y6N5 3/20 0.34
ADORA2A P29274 3/20 0.34
ADORA1 P30542 3/20 0.34
RXFP1 Q9HBX9 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP2C9 P11712 1/20 0.33
SCN9A Q15858 1/20 0.33
TOP1 P11387 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21279041 0.97 KDM4E (0.38) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL22563493 0.97 KDM4E (0.40) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL23487685 0.95 KDM4E (0.38) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL21279155 0.95 KDM4E (0.39) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL19942594 0.95 ALDH1A1 (0.34) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL19919806 0.94 KDM4E (0.39) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL23487680 0.93 KDM4E (0.39) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL21279040 0.92 KDM4E (0.38) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL21109633 0.92 ALDH1A1 (0.36) KDM4EALDH1A1L3MBTL1HPGDTDP1
SCHEMBL22562391 0.91 CTSS (0.37) KDM4EALDH1A1L3MBTL1HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 KDM4E 4619/4885ALDH1A1 80/4885L3MBTL1 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.